Altre lingue Invivyd, Inc.

Azioni

IVVD

US00534A1025

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 19/04/2024			Variaz. 5gg	Var. 1 gen.
2,3 ^USD	-2,13%		-22,03%	-41,62%

12/04	Invivyd nomina Jeremy Gowler come CEO ad interim	MT
12/04	Invivyd, Inc. annuncia cambiamenti a livello esecutivo	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Invivyd Announces CEO TransitionJeremy Gowler appointed Interim CEO	15/04
INVIVYD ANNOUNCES CEO TRANSITION	15/04
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™	15/04
Invivyd, Inc. Receives Healthcare Common Procedure Coding System Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services Covering Pemgarda	15/04
Invivyd Names Jeremy Gowler as Interim CEO	12/04
Invivyd, Inc. Announces Executive Changes	12/04
Invivyd Announces CEO Transition	12/04
Invivyd, Inc. Announces CEO Changes	12/04
North American Morning Briefing : Inflation Data, -2-	08/04
Invivyd's Pemgarda Injection to Prevent Covid Available in US -- Shares Rise After Hours	04/04
Invivyd Sees Covid-19 Prevention Treatment Revenue of Up to $200 Million This Year	04/04
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million	04/04
Invivyd, Inc. Provides Earnings Guidance for the Year 2024	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
Invivyd, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights	28/03
North American Morning Briefing : Stocks Edge -2-	27/03
Sector Update: Health Care Stocks Rise Tuesday Afternoon	26/03
Invivyd Clears Significant Hurdle After Pemgarda Authorization, Morgan Stanley Says	26/03
Top Premarket Gainers	26/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Invivyd, Inc.

Azioni

IVVD

US00534A1025

Altre lingue

Filtri